Amelioration of Ischemia- and Reperfusion-Induced Myocardial Injury by 17β-Estradiol

Abstract

Background 17β-Estradiol increases the production of nitric oxide (NO) and prostacyclin and opens Ca ²⁺ -activated K ⁺ (K _Ca ) channels. Whether these effects of 17β-estradiol reduce infarct size and the incidence of ventricular arrhythmia was investigated in dogs subjected to myocardial ischemia and reperfusion. Methods and Results Infarct size was measured in open-chest dogs after 90 minutes’ occlusion of the left anterior descending coronary artery and a subsequent 6 hours of reperfusion. Infusion of 17β-estradiol into the coronary artery was initiated 10 minutes before coronary occlusion and continued until after 1 hour of reperfusion, with the exception of the occlusion period. The difference in NO concentration between coronary venous and arterial blood 10 minutes after the onset of reperfusion was significantly greater in dogs treated with 17β-estradiol (10 ng · kg ⁻¹ · min ⁻¹ ) than in control animals. Infarct size (13.1±3.0% versus 43.7±5.4% of the area at risk) and the incidence of ventricular arrhythmia during ischemia and reperfusion periods were significantly reduced in the 17β-estradiol group. Both N G -nitro- l -arginine methyl ester (an inhibitor of NO synthase) and iberiotoxin (a blocker of K _Ca channels) reduced both the infarct size-limiting effect (infarct size, 29.3±3.0% and 31.7±2.1%, respectively) and the antiarrhythmic effect of 17β-estradiol; indomethacin (an inhibitor of cyclooxygenase) did not attenuate the beneficial effects of 17β-estradiol. Conclusions 17β-Estradiol reduced both myocardial infarct size and the occurrence of ischemia- and reperfusion-induced ventricular arrhythmias, which appear to be mediated by NO and the opening of K _Ca channels in canine hearts.